The Upjohn Company | Pfizer | Michigan | state | 2000 | undisclosed | | property tax abatement |
The Upjohn Company | Pfizer | Michigan | state | 1992 | undisclosed | | property tax abatement |
The Upjohn Company | Pfizer | Michigan | state | 1993 | undisclosed | | property tax abatement |
The Upjohn Company | Pfizer | Michigan | state | 1994 | undisclosed | | property tax abatement |
The Upjohn Company | Pfizer | Michigan | state | 1993 | undisclosed | | property tax abatement |
The Upjohn Company | Pfizer | Michigan | state | 1986 | undisclosed | | property tax abatement |
The Upjohn Company | Pfizer | Michigan | state | 1995 | undisclosed | | property tax abatement |
The Upjohn Company | Pfizer | Michigan | state | 1993 | undisclosed | | property tax abatement |
Teva Pharmceuticals USA Inc. | Teva Pharmaceutical Industries | New Jersey | State | 2018 | $39,998,730 | | tax credit/rebate |
Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | | $405,000 | | tax credit/rebate |
Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | | $345,000 | | tax credit/rebate |
Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | | $400,000 | | grant |
Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2009 | $145,313 | | tax credit/rebate |
Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2010 | $241,071 | | tax credit/rebate |
Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2011 | $10,746 | | tax credit/rebate |
Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2012 | $129,362 | | tax credit/rebate |
Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2017 | $137,235 | | tax credit/rebate |
Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | Kansas | state | 2016 | undisclosed | | grant |
Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | Kansas | state | 2017 | undisclosed | | grant |
Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | Kansas | state | 2018 | undisclosed | | grant |
TEVA Pharmaceuticals USA | Teva Pharmaceutical Industries | Pennsylvania | state | | $150,000 | | training reimbursement |
Teva Pharmaceuticals | Teva Pharmaceutical Industries | Kansas | state | 2014 | $3,861,454 | | grant |
Teva Pharmaceuticals | Teva Pharmaceutical Industries | Kansas | local | 2016 | $31,654 | | tax credit/rebate |
Teva Pharmaceuticals | Teva Pharmaceutical Industries | Kansas | local | 2017 | $37,036 | | tax credit/rebate |
Teva Pharmaceuticals | Teva Pharmaceutical Industries | Kansas | local | 2018 | $36,371 | | tax credit/rebate |
Teva Branded Pharmaceutical Products R&D, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2011 | $566,948 | | tax credit/rebate |
Teva Branded Pharmaceutical Products R&D, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2012 | $903,866 | | tax credit/rebate |
Teva Branded Pharmaceutical Products R&D, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2013 | $5,485,485 | | tax credit/rebate |
Teva Branded Pharmaceutical Products R&D, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2014 | $6,118,950 | | tax credit/rebate |
Teva Biopharmaceuticals, Inc. | Teva Pharmaceutical Industries | Maryland | state | 2010 | $42,015 | | tax credit/rebate |
TEVA Biopharmaceuticals, Inc. | Teva Pharmaceutical Industries | Maryland | state | 2011 | $26,524 | | tax credit/rebate |
Teva Biopharmaceuticals, Inc. | Teva Pharmaceutical Industries | Maryland | state | 2008 | $76,270 | | tax credit/rebate |
Teva Biopharmaceuticals, Inc. | Teva Pharmaceutical Industries | Maryland | state | 2012 | $50,570 | | tax credit/rebate |
TEVA Biopharmaceuticals, Inc. | Teva Pharmaceutical Industries | Maryland | state | 2009 | $41,319 | | tax credit/rebate |
Teva Biopharmaceuticals, Inc. | Teva Pharmaceutical Industries | Maryland | state | 2014 | $50,570 | | tax credit/rebate |
Teva Biopharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | Maryland | state | 2015 | $53,885 | | tax credit/rebate |
Teva Biopharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | Maryland | state | 2016 | $76,366 | | tax credit/rebate |
Teva Biopharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | Maryland | state | 2017 | $30,972 | | tax credit/rebate |
Taro Pharmaceuticals U.S.A., Inc. | Sun Pharmaceuticals | New Jersey | state | 2003 | $1,287,195 | | grant |
Takeda Pharmaceuticals North America, Inc. | Takeda Pharmaceutical | Illinois | state | 2005 | undisclosed | | tax credit/rebate |
Takeda Pharmaceuticals North America, Inc. | Takeda Pharmaceutical | Illinois | state | 2006 | undisclosed | | tax credit/rebate |
Takeda Pharmaceuticals North America, Inc. | Takeda Pharmaceutical | Illinois | state | 2007 | undisclosed | | tax credit/rebate |
Takeda Pharmaceuticals North America, Inc. | Takeda Pharmaceutical | Illinois | state | 2008 | $2,034,824 | | tax credit/rebate |
Takeda Pharmaceuticals North America, Inc. | Takeda Pharmaceutical | Illinois | state | 2009 | $4,511,785 | | tax credit/rebate |
Takeda Pharmaceuticals North America, Inc. | Takeda Pharmaceutical | Illinois | state | 2006 | $350,000 | | grant |
Takeda Pharmaceuticals North America, Inc. | Takeda Pharmaceutical | Illinois | state | 2007 | $350,000 | | grant |
Takeda Pharmaceuticals North America, Inc. | Takeda Pharmaceutical | Illinois | state | 2005 | $952,634 | | tax credit/rebate |
Takeda Pharmaceuticals North America, Inc. | Takeda Pharmaceutical | Illinois | state | 2006 | $1,384,120 | | tax credit/rebate |
Takeda Pharmaceuticals North America, Inc. | Takeda Pharmaceutical | Illinois | state | 2007 | undisclosed | | tax credit/rebate |
Takeda Pharmaceuticals North America, Inc. | Takeda Pharmaceutical | Illinois | state | 2008 | undisclosed | | tax credit/rebate |
Takeda Pharmaceuticals North America, Inc. | Takeda Pharmaceutical | Illinois | state | 2009 | $1,105,019 | | tax credit/rebate |
Takeda Pharmaceuticals America, Inc. | Takeda Pharmaceutical | Massachusetts | state | 2016 | $1,125,000 | | tax credit/rebate |
Takeda Pharmaceuticals America | Takeda Pharmaceutical | West Virginia | state | 2010 | undisclosed | | tax credit/rebate |
Synthes USA HQ, Inc. | Johnson & Johnson | Pennsylvania | state | 2009 | $53,661 | | tax credit/rebate |
SYNTHES U.S.A., LLC | Johnson & Johnson | New York | state | 2008 | $2,196,897 | | enterprise zone |
SYNTHES U.S.A., LLC | Johnson & Johnson | New York | state | 2009 | $2,600,000 | | enterprise zone |
SYNTHES U.S.A., LLC | Johnson & Johnson | New York | state | 2010 | $1,980,000 | | enterprise zone |
SYNTHES U.S.A., LLC | Johnson & Johnson | New York | state | 2001 | $620,000 | | enterprise zone |
SYNTHES U.S.A., LLC | Johnson & Johnson | New York | state | 2002 | $828,938 | | enterprise zone |
SYNTHES U.S.A., LLC | Johnson & Johnson | New York | state | 2011 | $2,366,358 | | enterprise zone |
SYNTHES U.S.A., LLC | Johnson & Johnson | New York | state | 2012 | $1,457,431 | | enterprise zone |
SYNTHES U.S.A., LLC | Johnson & Johnson | New York | state | 2013 | $2,311,702 | | enterprise zone |
SYNTHES U.S.A., LLC | Johnson & Johnson | New York | state | 2014 | $1,028,677 | | enterprise zone |
Synthes Spine, Inc. | Johnson & Johnson | Pennsylvania | state | 2008 | $344,128 | | tax credit/rebate |
Synthes North America, Inc. | Johnson & Johnson | Pennsylvania | state | 2008 | $90,887 | | tax credit/rebate |
Synthes North America, Inc. | Johnson & Johnson | Pennsylvania | state | 2009 | $76,539 | | tax credit/rebate |
SYNTHES (U.S.A.) | Johnson & Johnson | New York | state | 2006 | $2,697,365 | | enterprise zone |
SYNTHES (U.S.A.) | Johnson & Johnson | New York | state | 2007 | $2,870,000 | | enterprise zone |
SYNTHES (U.S.A.) | Johnson & Johnson | New York | state | 2004 | $1,130,588 | | enterprise zone |
SYNTHES (U.S.A.) | Johnson & Johnson | New York | state | 2005 | $1,985,000 | | enterprise zone |
SYNTHES (U.S.A.) | Johnson & Johnson | New York | state | 2003 | $939,077 | | enterprise zone |
Synageva BioPharma Corp | AstraZeneca | Massachusetts | state | 2013 | $784,000 | | tax credit/rebate |
Synageva BioPharma Corp | AstraZeneca | Massachusetts | state | 2015 | $900,000 | | tax credit/rebate |
Synageva BioPharma | AstraZeneca | Massachusetts | state | 2014 | $1,021,550 | | tax credit/rebate |
Supernus Pharmaceuticals | Supernus Pharmaceuticals | Maryland | local | 2019 | $500,000 | | grant/loan hybrid program |
Supernus Pharmaceuticals, Inc. | Supernus Pharmaceuticals | Maryland | state | 2007 | $15,373 | | training reimbursement |
Supernus Pharmaceuticals, Inc. | Supernus Pharmaceuticals | Maryland | state | 2018 | $44,733 | | training reimbursement |
Supernus Pharmaceuticals, Inc. | Supernus Pharmaceuticals | Maryland | state | 2018 | $38,025 | | tax credit/rebate |
Supernus Pharmaceuticals, Inc. | Supernus Pharmaceuticals | Maryland | state | 2019 | $62,460 | | tax credit/rebate |
Supernus Pharmaceuticals, Inc. | Supernus Pharmaceuticals | Maryland | state | 2020 | $65,492 | | tax credit/rebate |
Supernus Pharmaceuticals, Inc. | Supernus Pharmaceuticals | Maryland | state | 2021 | $100,088 | | tax credit/rebate |
Supernus Pharmaceuticals, Inc. | Supernus Pharmaceuticals | Maryland | state | 2022 | $0 | $800,000 | grant/loan hybrid program |
Supernus Pharmaceuticals | Supernus Pharmaceuticals | Maryland | local | 2018 | $500,000 | | grant/loan hybrid program |
Supernus Pharmaceuticals | Supernus Pharmaceuticals | Maryland | local | 2018 | $500,000 | | grant/loan hybrid program |
Supelco, Inc. | Merck KGaA (EMD) | Pennsylvania | state | 2009 | $6,462 | | tax credit/rebate |
Supelco, Inc. | Merck KGaA (EMD) | Pennsylvania | state | 2010 | $14,421 | | tax credit/rebate |
Supelco, Inc. | Merck KGaA (EMD) | Pennsylvania | state | 2011 | $18,828 | | tax credit/rebate |
Supelco, Inc. | Merck KGaA (EMD) | Pennsylvania | state | 2013 | $25,992 | | tax credit/rebate |
Supelco, Inc. | Merck KGaA (EMD) | Pennsylvania | state | 2015 | $17,786 | | tax credit/rebate |
Sun Pharmaceutical Industries, Inc. | Sun Pharmaceuticals | New Jersey | state | 2008 | $2,382,217 | | grant |
Sucampo Pharmaceuticals, Inc. | Mallinckrodt | Maryland | state | 2004 | $50,128 | | tax credit/rebate |
Sucampo Pharmaceuticals, Inc. | Mallinckrodt | Maryland | state | 2007 | $31,263 | | tax credit/rebate |
Sucampo Pharmaceuticals, Inc. | Mallinckrodt | Maryland | state | 2016 | $450,000 | | grant/loan hybrid program |
Sucampo Pharmaceuticals, Inc. | Mallinckrodt | Maryland | state | 2016 | $4,740 | | tax credit/rebate |
SUCAMPO PHARMACEUTICALS INC | Mallinckrodt | Maryland | local | 2016 | $300,000 | | grant/loan hybrid program |
Sucampo Pharma Americas, Inc. | Mallinckrodt | Maryland | state | 2010 | $15,746 | | tax credit/rebate |
Sucampo Pharma Americas, Inc. | Mallinckrodt | Maryland | state | 2011 | $37,575 | | tax credit/rebate |
Sucampo Pharma Americas, Inc. | Mallinckrodt | Maryland | state | 2009 | $17,600 | | tax credit/rebate |
Steel Forest, LLC | AbbVie | New York | local | 2015 | $641,296 | | tax credit/rebate |
Steel Forest, LLC | AbbVie | New York | local | 2016 | $254,454 | | tax credit/rebate |
Steel Forest, LLC | AbbVie | New York | local | 2017 | $275,871 | | tax credit/rebate |